| {"0": "Electron transport chain oxphos system in mitochondria", "1": "Ferroptosis", "2": "Nonalcoholic fatty liver disease", "3": "Sphingolipid metabolism overview", "4": "Sphingolipid metabolism integrated pathway", "5": "Sphingolipid pathway", "6": "Mitochondrial complex i assembly model oxphos system", "7": "Overlap between signal transduction pathways contributing to lmna laminopathies", "8": "Metapathway biotransformation phase i and ii", "9": "Glycerophospholipid biosynthetic pathway", "10": "Cholesterol metabolism with bloch and kandutschrussell pathways", "11": "Oxidative phosphorylation", "12": "Proteoglycan biosynthesis", "13": "Allograft rejection", "14": "Envelope proteins and their potential roles in edmd physiopathology", "15": "Adipogenesis", "16": "Ppar signaling pathway", "17": "Mitochondrial long chain fatty acid betaoxidation", "18": "Alzheimers disease and mirna effects", "19": "Apoptosis modulation and signaling", "20": "Circadian rhythm genes", "21": "Alzheimers disease", "22": "Nuclear receptors metapathway", "23": "Angiopoietinlike protein 8 regulatory pathway", "24": "Cellular proteostasis", "25": "Il9 signaling pathway", "26": "Pdgfrbeta pathway", "27": "Serotonin htr1 group and fos pathway", "28": "Mirna regulation of prostate cancer signaling pathways", "29": "Il7 signaling pathway", "30": "Fgfr3 signaling in chondrocyte proliferation and terminal differentiation"} |